Therapeutic targeting of the tumor microenvironments with cannabinoids and their analogs: Update on clinical trials
- 3 May 2023
- journal article
- review article
- Published by Elsevier in Environmental Research
- Vol. 231 (Pt 1) , 115862
Abstract
No abstract availableKeywords
Funding Information
- National Research Foundation of Korea (2021R1A5A6002853)
- Ministry of Science, ICT and Future Planning
This publication has 157 references indexed in Scilit:
- Anti-tumoral action of cannabinoids on hepatocellular carcinoma: role of AMPK-dependent activation of autophagyCell Death & Differentiation, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppressionImmunobiology, 2010
- A role for L‐α‐lysophosphatidylinositol and GPR55 in the modulation of migration, orientation and polarization of human breast cancer cellsBritish Journal of Pharmacology, 2010
- TH17 cells in tumour immunity and immunotherapyNature Reviews Immunology, 2010
- The tumor microenvironment and its role in promoting tumor growthOncogene, 2008
- Cannabinoids reduce granuloma‐associated angiogenesis in rats by controlling transcription and expression of mast cell protease‐5British Journal of Pharmacology, 2008
- Cancer-related inflammationNature, 2008
- Tumor immunoediting and immunosculpting pathways to cancer progressionSeminars in Cancer Biology, 2007
- A pilot clinical study of Δ9-tetrahydrocannabinol in patients with recurrent glioblastoma multiformeBritish Journal of Cancer, 2006